Matches in SemOpenAlex for { <https://semopenalex.org/work/W2788394814> ?p ?o ?g. }
- W2788394814 endingPage "436" @default.
- W2788394814 startingPage "428" @default.
- W2788394814 abstract "Metamizole ( MT ), an analgesic and antipyretic drug, is rapidly hydrolyzed to the active primary metabolite 4‐methylaminoantipyrine ( MAA ) and relatively active secondary metabolite 4‐aminoantipyrine ( AA ). The aim of this study was to assess the pharmacokinetic profiles of MAA and AA after dose of 25 mg/kg MT by intravenous (i.v.), intramuscular (i.m.), oral (p.o.), and rectal ( RC ) routes in dogs. Six dogs were randomly allocated to an open, single‐dose, four‐treatment, four‐phase, unpaired, crossover study design. Blood was collected at predetermined times within 24 hr, and plasma was analyzed by a validated HPLC ‐ UV method. Plasma concentrations of MAA and AA after i.v., i.m., p.o., and RC administrations of MT were detectable from 5 (i.v. and i.m.) or 30 (p.o. and RC ) min to 24 hr in all dogs. The highest concentrations of MAA were found in the i.v., then i.m., p.o., and RC groups. Plasma concentrations of AA were similar for i.v., i.m., and RC , and the concentrations were approximately double those in the PO groups. The AUC EV/IV ratio for MAA was 0.75 ± 0.11, 0.59 ± 0.08, and 0.32 ± 0.05, for i.m., p.o., and RC , respectively. The AUC EV / IV ratio for AA was 1.21 ± 0.33, 2.17 ± 0.62, and 1.08 ± 0.19, for i.m., p.o., and RC , respectively. Although further studies are needed, rectal administration seems to be the least suitable route of administration for MT in the dog." @default.
- W2788394814 created "2018-03-06" @default.
- W2788394814 creator A5004165781 @default.
- W2788394814 creator A5007611168 @default.
- W2788394814 creator A5011235762 @default.
- W2788394814 creator A5067124963 @default.
- W2788394814 creator A5071709539 @default.
- W2788394814 creator A5079644525 @default.
- W2788394814 creator A5086237413 @default.
- W2788394814 date "2018-01-19" @default.
- W2788394814 modified "2023-10-01" @default.
- W2788394814 title "Pharmacokinetic profiles of the active metamizole metabolites after four different routes of administration in healthy dogs" @default.
- W2788394814 cites W1607947540 @default.
- W2788394814 cites W1786820685 @default.
- W2788394814 cites W1869158856 @default.
- W2788394814 cites W1965763256 @default.
- W2788394814 cites W1971178236 @default.
- W2788394814 cites W1974011879 @default.
- W2788394814 cites W1976016598 @default.
- W2788394814 cites W1982192328 @default.
- W2788394814 cites W2001174383 @default.
- W2788394814 cites W2014051487 @default.
- W2788394814 cites W2019236523 @default.
- W2788394814 cites W2024289681 @default.
- W2788394814 cites W2031702137 @default.
- W2788394814 cites W2032790102 @default.
- W2788394814 cites W2043276078 @default.
- W2788394814 cites W2053139543 @default.
- W2788394814 cites W2065209479 @default.
- W2788394814 cites W2067066717 @default.
- W2788394814 cites W2081702101 @default.
- W2788394814 cites W2085767678 @default.
- W2788394814 cites W2099341361 @default.
- W2788394814 cites W2099945917 @default.
- W2788394814 cites W2100655473 @default.
- W2788394814 cites W2102206508 @default.
- W2788394814 cites W2102930371 @default.
- W2788394814 cites W2104764302 @default.
- W2788394814 cites W2106633191 @default.
- W2788394814 cites W2128289223 @default.
- W2788394814 cites W2133272016 @default.
- W2788394814 cites W2134001774 @default.
- W2788394814 cites W2150905634 @default.
- W2788394814 cites W2396778315 @default.
- W2788394814 cites W2494042001 @default.
- W2788394814 cites W2509827322 @default.
- W2788394814 cites W277290643 @default.
- W2788394814 cites W4231421929 @default.
- W2788394814 doi "https://doi.org/10.1111/jvp.12484" @default.
- W2788394814 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29352476" @default.
- W2788394814 hasPublicationYear "2018" @default.
- W2788394814 type Work @default.
- W2788394814 sameAs 2788394814 @default.
- W2788394814 citedByCount "13" @default.
- W2788394814 countsByYear W27883948142018 @default.
- W2788394814 countsByYear W27883948142019 @default.
- W2788394814 countsByYear W27883948142021 @default.
- W2788394814 countsByYear W27883948142022 @default.
- W2788394814 countsByYear W27883948142023 @default.
- W2788394814 crossrefType "journal-article" @default.
- W2788394814 hasAuthorship W2788394814A5004165781 @default.
- W2788394814 hasAuthorship W2788394814A5007611168 @default.
- W2788394814 hasAuthorship W2788394814A5011235762 @default.
- W2788394814 hasAuthorship W2788394814A5067124963 @default.
- W2788394814 hasAuthorship W2788394814A5071709539 @default.
- W2788394814 hasAuthorship W2788394814A5079644525 @default.
- W2788394814 hasAuthorship W2788394814A5086237413 @default.
- W2788394814 hasBestOaLocation W27883948141 @default.
- W2788394814 hasConcept C112705442 @default.
- W2788394814 hasConcept C142724271 @default.
- W2788394814 hasConcept C149151106 @default.
- W2788394814 hasConcept C179998833 @default.
- W2788394814 hasConcept C185592680 @default.
- W2788394814 hasConcept C204787440 @default.
- W2788394814 hasConcept C27081682 @default.
- W2788394814 hasConcept C2777056448 @default.
- W2788394814 hasConcept C2777477808 @default.
- W2788394814 hasConcept C2778808936 @default.
- W2788394814 hasConcept C2779252780 @default.
- W2788394814 hasConcept C2780820201 @default.
- W2788394814 hasConcept C43617362 @default.
- W2788394814 hasConcept C55493867 @default.
- W2788394814 hasConcept C71924100 @default.
- W2788394814 hasConcept C87813604 @default.
- W2788394814 hasConcept C98274493 @default.
- W2788394814 hasConceptScore W2788394814C112705442 @default.
- W2788394814 hasConceptScore W2788394814C142724271 @default.
- W2788394814 hasConceptScore W2788394814C149151106 @default.
- W2788394814 hasConceptScore W2788394814C179998833 @default.
- W2788394814 hasConceptScore W2788394814C185592680 @default.
- W2788394814 hasConceptScore W2788394814C204787440 @default.
- W2788394814 hasConceptScore W2788394814C27081682 @default.
- W2788394814 hasConceptScore W2788394814C2777056448 @default.
- W2788394814 hasConceptScore W2788394814C2777477808 @default.
- W2788394814 hasConceptScore W2788394814C2778808936 @default.
- W2788394814 hasConceptScore W2788394814C2779252780 @default.
- W2788394814 hasConceptScore W2788394814C2780820201 @default.
- W2788394814 hasConceptScore W2788394814C43617362 @default.